Cargando…
Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization
BACKGROUND: Previous reports have indicated that matrix metallopeptidase-2 (MMP-2) regulates angiogenic processes, which are involved in choroidal neovascularization (CNV). However, the regulation of MMP-2 in CNV has not been well-characterized. To gain more information about the regulation of MMP-2...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030271/ https://www.ncbi.nlm.nih.gov/pubmed/24886609 http://dx.doi.org/10.1186/1742-2094-11-88 |
_version_ | 1782317366725574656 |
---|---|
author | Cai, Jingjing Yin, Guibin Lin, Bing Wang, Xianwei Liu, Xiaoling Chen, Xiaoyan Yan, Dongsheng Shan, Ge Qu, Jia Wu, Shengzhou |
author_facet | Cai, Jingjing Yin, Guibin Lin, Bing Wang, Xianwei Liu, Xiaoling Chen, Xiaoyan Yan, Dongsheng Shan, Ge Qu, Jia Wu, Shengzhou |
author_sort | Cai, Jingjing |
collection | PubMed |
description | BACKGROUND: Previous reports have indicated that matrix metallopeptidase-2 (MMP-2) regulates angiogenic processes, which are involved in choroidal neovascularization (CNV). However, the regulation of MMP-2 in CNV has not been well-characterized. To gain more information about the regulation of MMP-2 in CNV, we analyzed the circuitry associated with MMP-2 regulation in a CNV model and in cell cultures, focusing on NFκB and the microRNA-29 family (miR-29s). METHODS: The CNV model was established by subjecting C57BL/6 mice to fundus photocoagulation with a krypton red laser. In choroidal-retinal pigment epithelial (RPE) tissues of the model, immunohistochemistry was used to evaluate the angiogenesis and MMP-2 expression; reverse-transcription quantitative PCR (RT-qPCR) was used to determine the levels of miR-29s; and western blot was used to analyze the protein levels of nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) inhibitor, IκBα, and its phosphorylated form, phospho-IκBα. At the cellular level, RT-qPCR was used to examine the levels of miR-29s following NFκB activation by tumor necrosis factor alpha (TNFα); and western blot and luciferase assay were used to determine the regulation of MMP-2 by miR-29s in a human RPE cell line (ARPE-19) and in an umbilical vein endothelial cell line (EA hy926). RESULTS: MMP-2 staining was increased in the choroidal neovascular membrane of laser-treated retina. Also, the NFκB pathway was induced in choroid-RPE tissue, as evidenced by a lower protein level of IκBα and a higher level of phospho-IκBα in the tissue homogenates than in those from non-treated eyes. During the period when the NFκB pathway was induced, reduced miR-29s were detected in the choroidal-RPE tissue of the laser-treated eyes. In cultured ARPE-19 cells, TNFα decreased miR-29a, b, and c, and the effects were rescued by NFκB decoy. In ARPE-19 and EA hy926, miR-29s mimics reduced the contents of secreted MMP-2 in the culture media. We also documented that miR-29s reduced MMP-2 3’-UTR-mediated luciferase transcription. CONCLUSIONS: The results suggest that in CNV, NFκB activation inhibits miR-29s, which may contribute to angiogenesis by up-regulating the MMP-2 protein level in RPE cells. These observations may help in developing a strategy for resolving CNV by targeting miR-29s levels. |
format | Online Article Text |
id | pubmed-4030271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40302712014-05-23 Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization Cai, Jingjing Yin, Guibin Lin, Bing Wang, Xianwei Liu, Xiaoling Chen, Xiaoyan Yan, Dongsheng Shan, Ge Qu, Jia Wu, Shengzhou J Neuroinflammation Research BACKGROUND: Previous reports have indicated that matrix metallopeptidase-2 (MMP-2) regulates angiogenic processes, which are involved in choroidal neovascularization (CNV). However, the regulation of MMP-2 in CNV has not been well-characterized. To gain more information about the regulation of MMP-2 in CNV, we analyzed the circuitry associated with MMP-2 regulation in a CNV model and in cell cultures, focusing on NFκB and the microRNA-29 family (miR-29s). METHODS: The CNV model was established by subjecting C57BL/6 mice to fundus photocoagulation with a krypton red laser. In choroidal-retinal pigment epithelial (RPE) tissues of the model, immunohistochemistry was used to evaluate the angiogenesis and MMP-2 expression; reverse-transcription quantitative PCR (RT-qPCR) was used to determine the levels of miR-29s; and western blot was used to analyze the protein levels of nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) inhibitor, IκBα, and its phosphorylated form, phospho-IκBα. At the cellular level, RT-qPCR was used to examine the levels of miR-29s following NFκB activation by tumor necrosis factor alpha (TNFα); and western blot and luciferase assay were used to determine the regulation of MMP-2 by miR-29s in a human RPE cell line (ARPE-19) and in an umbilical vein endothelial cell line (EA hy926). RESULTS: MMP-2 staining was increased in the choroidal neovascular membrane of laser-treated retina. Also, the NFκB pathway was induced in choroid-RPE tissue, as evidenced by a lower protein level of IκBα and a higher level of phospho-IκBα in the tissue homogenates than in those from non-treated eyes. During the period when the NFκB pathway was induced, reduced miR-29s were detected in the choroidal-RPE tissue of the laser-treated eyes. In cultured ARPE-19 cells, TNFα decreased miR-29a, b, and c, and the effects were rescued by NFκB decoy. In ARPE-19 and EA hy926, miR-29s mimics reduced the contents of secreted MMP-2 in the culture media. We also documented that miR-29s reduced MMP-2 3’-UTR-mediated luciferase transcription. CONCLUSIONS: The results suggest that in CNV, NFκB activation inhibits miR-29s, which may contribute to angiogenesis by up-regulating the MMP-2 protein level in RPE cells. These observations may help in developing a strategy for resolving CNV by targeting miR-29s levels. BioMed Central 2014-05-15 /pmc/articles/PMC4030271/ /pubmed/24886609 http://dx.doi.org/10.1186/1742-2094-11-88 Text en Copyright © 2014 Cai et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Cai, Jingjing Yin, Guibin Lin, Bing Wang, Xianwei Liu, Xiaoling Chen, Xiaoyan Yan, Dongsheng Shan, Ge Qu, Jia Wu, Shengzhou Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization |
title | Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization |
title_full | Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization |
title_fullStr | Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization |
title_full_unstemmed | Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization |
title_short | Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization |
title_sort | roles of nfκb-mir-29s-mmp-2 circuitry in experimental choroidal neovascularization |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030271/ https://www.ncbi.nlm.nih.gov/pubmed/24886609 http://dx.doi.org/10.1186/1742-2094-11-88 |
work_keys_str_mv | AT caijingjing rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization AT yinguibin rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization AT linbing rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization AT wangxianwei rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization AT liuxiaoling rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization AT chenxiaoyan rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization AT yandongsheng rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization AT shange rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization AT qujia rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization AT wushengzhou rolesofnfkbmir29smmp2circuitryinexperimentalchoroidalneovascularization |